Sage Journals: Discover world-class research

Open access

Research article

First published 2018-4

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies

Mark S Freedman, Jerry S Wolinsky, Giancarlo Comi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2020-10

Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis

Natalie A Schwehr, Karen M Kuntz, Mary Butler [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-4

Peripartum disease activity in moderately and severely disabled women with multiple sclerosis

Bridget LaMonica Ostrem, Annika Anderson, Sarah Conway [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2023-4

The impact of relapse definition and measures of durability on MS clinical trial outcomes

Sammita Satyanarayan, Gary Cutter, Stephen Krieger [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-5

Significant clinical worsening after natalizumab withdrawal: Predictive factors

A Vidal-Jordana, M Tintoré, C Tur [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-8

Effectiveness of cladribine compared to fingolimod,natalizumab,ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2020-7

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Kevin Ahrweiller, Chloé Rousseau, Emmanuelle Le Page [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2026-3

Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)—A meta-regression of randomized controlled trials

Roxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021

Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results

Ralf Gold, Douglas L Arnold, Amit Bar-Or [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-3

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre,Italian,retrospective,observational study

Damiano Baroncini, Mauro Zaffaroni, Lucia Moiola [...]

Multiple Sclerosis Journal

Search results